TUMORI, vol.89, no.2, pp.141-145, 2003 (SCI-Expanded)
Article / Article
Science Citation Index Expanded (SCI-EXPANDED), Scopus
colorectal cancer, irinotecan, recurrent, PHASE-II, CAMPTOTHECIN, CPT-11, TRIAL, PHARMACOKINETICS, FLUOROURACIL, CARCINOMA, SN-38
Dokuz Eylül University Affiliated:
Aims and background: We evaluated the efficacy and tolerability of weekly irinotecan as a second-line treatment in patients with colorectal cancer failing 5-fluorouracil-based chemotherapy and searched for predictive and prognostic factors.